Fulton Murray

Dose Therapeutics, Inc. is an early-stage biotechnology company based in Dallas, TX. Dose Therapeutics focuses on providing solutions for unmet medical needs, with a particular focus on high-risk neuroblastoma, an aggressive and often deadly form of childhood cancer. The company's first development candidate uses the tagging of a protein for degradation to potentially provide a new treatment option for children suffering from neuroblastoma. The company was founded by Steven L. McKnight and Deepak Nijhawan.

Founded in 1998, Covera Ventures, formerly Hunt Ventures, is a venture capital firm headquartered in Dallas, Texas. The firm spun out from Hunt Consolidated, Inc. in 2009.

Athenix Corp. develops agricultural herbicide tolerance and insect control chemicals. It provides genes, proteins, processes, traits, and transgenic organisms for multiple sectors including seed, agricultural chemical, specialty chemical, industrial enzymes, and energy. The company was founded by Duck Nicholas Barbara, Carozzi Nadine and Koziel Michael Gene in 2001 and is headquartered in Raleigh, NC.